ACROPASS TROUBLE CURE (RAPHAS CO.,LTD)


Welcome to the PulseAid listing for the ACROPASS TROUBLE CURE drug offered from RAPHAS CO.,LTD. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: RAPHAS CO.,LTD
NON-PROPRIETARY NAME: HYALURONIC ACID, NIACINAMIDE
SUBSTANCE NAME: HYALURONIC ACID; NIACINAMIDE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: TOPICAL
DOSAGE FORM: PATCH
MARKETING CATEGORY NAME: UNAPPROVED DRUG OTHER
START MARKETING DATE: 2016-11-01
END MARKETING DATE: 0000-00-00


ACROPASS TROUBLE CURE HUMAN OTC DRUG Details:

Item DescriptionACROPASS TROUBLE CURE from RAPHAS CO.,LTD
LABELER NAME: RAPHAS CO.,LTD
DEA SCHEDULE:
ACTIVE STRENGTH: .53; .03(mg/.58mg; mg/.58mg)
START MARKETING DATE: 2016-11-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 71134-010_855d195c-9ed6-4c07-a003-75edb6bcf622
PRODUCT NDC: 71134-010
APPLICATION NUMBER:

Other HYALURONIC ACID; NIACINAMIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
RAPHAS CO.,LTDACROPASS TROUBLE CURE